2019 Recipients
Martin Cornillet, PhD
Karolinska Institute, Center for Infectious Medicine (CIM)
“Tissue-resident Natural Killer Cells In Human Liver Cancer”
Marta Valera-Rey, PhD
CIC bioGUNE
"Metabolic Adaptation As An Essential Requirement For Liver Regeneration"
Adriaan Holleboom, MD, PhD
Amsterdam University Medical Center, location AMC
“Lipophagy In Non-alcoholic Steatohepatitis: A Translational Journey From Rare Defects To Novel treatment Target”
2018 Recipients
Francisco Javier Cubero, PhD
Complutense University School of Medicine
Madrid, Spain
Interdependence of Oxidative Stress and Inflammation during Chronic Liver Injury: A Novel Tool for Theranostics
Tetyana Yevsa, PhD
Hannover Medical School
Hannover, Germany
Deciphering the Role of B Lymphocytes in Fatty- and Other Precancerous Liver Diseases
Thomas Reiberger, MD
Medical University of Vienna
Vienna, Austria
Characterization of Gut-Liver Fxr–Fgf19 Signaling in Cirrhotic Patients with Portal Hypertension
2017 Recipients
Salvador Augustin, MD, PhD
Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) Universitat Autònoma de Barcelona
Barcelona, Spain
Towards the Development of Next-Generation Microbiome-Based Therapeutics in NASH and Portal Hypertension Based on a Polyphasic Microbiological Approach
Christoph Welsch, MD
J. W. Goethe University Hospital
Frankfurt, Germany
Role of the Lipid Environment for HCV Replication and Disease Progression
Hannelie Korf, PhD
The Katholieke Universiteit Leuven
Leuven, Belgium
Deciphering the Role of Adipose Tissue Inflammation and Adipose Tissue Derived Secreted Factors in the Pathogenesis of Non Alcoholic Steatohepatitis (NASH): A Translational Study
2016 Recipients
Jordi Gracia-Sancho, PhD
IDIBAPS Research Institute
Barcelona, Spain
Capillarization of the Liver Sinusoidal Endothelium: Orchestration by miRNAs
Niv Zmora, PhD
Weizmann Institute of Science
Rehovot, Israel
Deciphering the Role of Gut Microbiota in the Development of Promary Sclerosing Cholangitis (PSC)
Julie Lucifora, PhD
INSERM
Lyon, France
Inhibition of HDV Replication by Inducers of the NF-kB Pathway: Mechanistic Insights and Pespectives towards a Cure of HDV Infection
2015 Recipients
Rui Eduardo Castro, PhD
The Research Institute for Medicines, University of Lisbon
Lisbon, Portugal
Role of Mitofusin 2 in Non-Alcoholic Fatty Liver Disease and Targeting microRNAs
Jérôme Gouttenoire, PhD
CHUV-University of Lausanne
Lausanne, Switzerland
Structure and Function of Hepatitis E Virus ORF3 Protein
Qingfeng Chen, PhD
Institute of Molecular and Cell Biology, Agency for Science, Technology and Research
Singapore
Targeting the Calcium-Activated Potassium Channel KCa3.1 for Therapy of Liver Fibrosis in a Novel Humanized Mouse Model of Hepatitis C Virus Infection
2014 Recipients
Laura Belloni, PhD
Sapienza University of Rome
Rome, Italy
Targeting Viral cccDNA for HBV Cure: From Understanding the Epigenetic Mechanisms That Control cccDNA Function and Stability to New Treatment Strategies and Biomarkers
Christophe Rodriguez, PhD, PharmD
Henri Mondor Hospital/University Paris-Est Créteil
Créteil, France
Study of the Transactivation Properties of Hepatitis C Virus NS5A Protein and Their Role in the HCV Lifecycle and Liver Carcinogenesis by Means of Next-Generation Sequencing and Original Cellular and Animal Models
I-Cheng Lee, MD
Taipei Veterans General Hospital
Taipei, Taiwan
Generation of Antiviral Immunity Against HBV by Modulating Pathogen Recognition Receptor-Mediated Innate Immunity in HBV Mice Model
2013 Recipients
Vincenzo La Mura, MD, PhD
IRCCS-Ca′Granda, Ospedale Policlinico Maggiore
Milan, Italy
Vascular Inflammation During Sepsis Causes Prognosis Worsening in Patients with Cirrhosis and Portal Hypertension: Effects of Simvastatin
Amar Deep Sharma, PhD
Hannover Medical School
Hannover, Germany
Modulation of microRNA-221 as a Therapeutic Intervener of Liver Fibrosis